4//SEC Filing
Musso Alan A 4
Accession 0000950170-24-009094
CIK 0001680581other
Filed
Jan 29, 7:00 PM ET
Accepted
Jan 30, 9:05 PM ET
Size
5.3 KB
Accession
0000950170-24-009094
Insider Transaction Report
Form 4
Musso Alan A
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2024-01-26+100,000→ 100,000 totalExercise: $6.95Exp: 2034-01-25→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]This option was granted on January 26, 2024 and is scheduled to vest in equal quarterly installments over four years beginning on the vesting commencement date of January 1, 2024, subject to the reporting person's continued service on each such vesting date.
Documents
Issuer
Fulcrum Therapeutics, Inc.
CIK 0001680581
Entity typeother
Related Parties
1- filerCIK 0001295830
Filing Metadata
- Form type
- 4
- Filed
- Jan 29, 7:00 PM ET
- Accepted
- Jan 30, 9:05 PM ET
- Size
- 5.3 KB